Pricing Log in Create free account

Adlai Nortye Ltd. Sponsored ADR (ANL) vs Lexicon Pharmaceuticals, Inc. (LXRX)

Adlai Nortye Ltd. Sponsored ADR and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Adlai Nortye Ltd. Sponsored ADR and Lexicon Pharmaceuticals, Inc. are of similar size ($734.2M and $710.1M). Across the 9 metrics below, Adlai Nortye Ltd. Sponsored ADR leads on 7 and Lexicon Pharmaceuticals, Inc. on 2.

Valuation

Metric ANL LXRX Biotechnology median
P/E — n/m 8.50
P/S — 16.04 9.71
P/B n/m 3.81 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 12.80 9.21
Earnings yield — (10.04%) (33.15%)
Free cash flow yield 0.00% (9.92%) (25.50%)

Profitability

Metric ANL LXRX Biotechnology median
Gross margin — 99.14% 65.16%
Operating margin — (131.43%) 0.00%
Net margin — (147.38%) 0.00%
Free cash flow margin 0.00% (156.71%) 0.00%
Return on equity 0.00% (40.21%) (56.36%)
Return on assets 0.00% (25.70%) (48.04%)
Return on invested capital 0.00% (96.36%) 0.00%

Growth

Metric ANL LXRX Biotechnology median
Revenue growth (TTM) — (29.03%) 6.02%
EPS growth (last fiscal year) 31.48% 77.78% 30.26%
Revenue growth, 5-year CAGR — 15.72% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ANL LXRX Biotechnology median
Debt to equity 0.12 0.29 0.00
Current ratio 9.55 13.37 4.72
Net debt to EBITDA (0.05) 0.91 0.96

Dividend

Metric ANL LXRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANL LXRX Biotechnology median
Market cap 710.05m 734.18m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack